Cite
HARVARD Citation
Takeuchi, T. et al. (2013). FRI0200 Achievement of low disease activity (LDA) at 3 months predicts clinical remission (REM) at 1 year of infliximab (IFX) therapy in ra: post-hoc analysis of a randomized double-blind clinical study (rising study). Annals of the rheumatic diseases. pp. A439-A440. [Online].